Pulmonary hypertension secondary to obstructive sleep apnea-hypopnea syndrome.
DOI:
https://doi.org/10.35954/SM2019.38.2.8Keywords:
Sleep Apnea, Obstructive; Hypertension, Pulmonary; Heart Failure; Sleep Apnea SyndromesAbstract
Pulmonary Hypertension defined as a mean pulmonary pressure greater than 20-25 mmHg may be secondary to multiple pathologies, with respiratory diseases playing a fundamental role.
The clinical case of a patient with right-sided heart failure with severe pulmonary hypertension, confirmed by transthoracic echocardiogram, is described below. We highlight the confirmation of the diagnosis through the right cardiac catheterization that classifies this case within subgroup 3 of pulmonary arterial hypertension, that is secondary to pulmonary diseases. As the search for a etiology progresses, the syndrome of Obstructive Apnea-Hypopnea of severe sleep arises. This hidden cause is relatively frequent in overweight obese people, however, it is rare as the only cause of severe hypertension. It is recognized that the most frequent pathologies in subgroup 3 are: chronic obstructive pulmonary disease, interstitiopathies and the combination of parenchymal fibrosis and emphysema.
The objective of this work is to report an infrequent case in clinical practice due to its form of presentation and its determining causes and to carry out a brief review of the diagnostic algorithm.
Downloads
Metrics
References
(1) Cadenas Menéndez S, Martin Moreiras J, Álvarez Vega P, González Calle D, Oterino Manzanas A, Escribano Subias P, et al. Hipertensión pulmonar (I). Hipertensión arterial pulmonar. Servicios de Neumología y Cardiología. Complejo Asistencial Universitario de Salamanca. Salamanca. España. Unidad Multidisciplinar de Hipertensión Pulmonar. Hospital Universitario. Medicine 2017; 12(45):2655-73. doi: 10.1016/j.med.2017.11.003
(2) Barberà JA, Román A, Gómez-Sánchez MA, Blanco I, Otero R. Diagnóstico y tratamiento de la hipertensión pulmonar. Barcelona: SEPAR/Respira, 2017. 56 p. Disponible en:http://issuu.com/separ/docs/normativa_70?=3049452/44188557 [Consulta 20/07/2019].
(3) Consenso Nacional sobre el síndrome de Apneas - Hipopneas del sueño. Sociedad Española de Neumología y Cirugía Torácica. Asociación Latinoamericana del Tórax. Asociación Sudamericana de Cirugía Torácica. Arch Bronconeumol 2005; 41 Supl 4:7-9.
(4) Morales-Blanhir JE, Valencia-Flores M, Lozano-Cruz OA. El síndrome de apnea obstructiva del sueño como factor de riesgo para enfermedades cardiovasculares y su asociación con hipertensión pulmonar. Neumol Cir Tórax 2017; 76(1):51-60.
(5) Escribano Subías P. Comentarios a la guía ESC/ERS 2015 sobre el diagnóstico y tratamiento de la hipertensión pulmonar. Rev Esp Cardiol 2016; 69(2):102-8. doi: 10.1016/j.recesp.2015.11.032
(6) Barberà JA, Román A, Gómez-Sánchez MA, Blanco I, Otero R, López-Reyes R, et al. Guía de diagnóstico y tratamiento de la hipertensión pulmonar. Arch Bronconeumol 2018; 54(4):205-15. doi: 10.1016/j.arbres.2017.11.014
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
